Arkolith/Funds/Beryl Capital Management LLC

Beryl Capital Management LLC

CIK 1719307
Holdings as of Mar 31, 2026·disclosed May 15, 2026·~45-day 13F lag·13F-HR
Active Filer

Beryl Capital Management LLC holds a concentrated book of 8 stocks worth $108.6M as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened MASIMO CORP. Their largest long position is MASIMO CORP at 36% of the equity book. They also disclosed $1.1M in call options (bullish), shown separately below and excluded from the equity book.

Build

Build on this 13F portfolio

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp
Build

Ask your agent what Beryl Capital Management LLC owns

This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.

Get a key Compare plans13F data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/funds/1719307/holdings"
Ask your agent
Use Arkolith to show Beryl Capital Management LLC's latest
holdings, largest changes, and filing provenance.
Opened
7
new positions
Added to
1
existing
Trimmed
0
reduced
Sold out
14
exited

Concentration

Top-heavy: concentrated book

Top 5 holdings
92%
Top 10 holdings
100%
Top 20 holdings
100%

Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.

Direct sector allocation

36% mapped to company sectors

ETF / fund or unclassified
64%
Health Care
36%

Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.

Biggest moves: latest quarter

Estimated $ traded · quarter-end prices, no cost basis

Bought
  • MASIMO CORPMASI
    ▲New$38.6M
  • TERNS PHARMACEUTICALS INC
    ▲New$25.2M
  • GREAT LAKES DREDGE & DOCK CO
    ▲New$15.5M
  • DAY ONE BIOPHARMACEUTICALS I
    ▲New$11.0M
  • SUNOPTA INCSTKL
    ▲New$9.8M
  • WARNER BROS DISCOVERY INC
    ▲+184%$3.3M
Trimmed / exited
  • ELECTRONIC ARTS INC
    ▼−100%
  • EXACT SCIENCES CORP
    ▼−100%
  • CLEARWATER ANALYTICS HLDGS I
    ▼−100%
  • INSPIRATO INCORPORATED
    ▼−100%
  • INTERNATIONAL MNY EXPRESS IN
    ▼−100%
  • JAMF HLDG CORP
    ▼−100%

Holdings: largest first

Bars show each stock's share of the portfolio. Click a row for its position history.

8 positions
#SecurityValueShares% PortLast moveHistory
1Masimo Corp
COM
$38.6M217.1K
35.5%
▲New
New position
2Terns Pharmaceuticals Inc
COM
$25.2M478.8K
23.2%
▲New
New position
3Great Lakes Dredge & Dock Co
COM
$15.5M912.5K
14.3%
▲New
New position
4Day One Biopharmaceuticals I
COM
$11.0M514.1K
10.1%
▲New
New position
5Sunopta Inc
COM
$9.8M1.51M
9.0%
▲New
New position
6Warner Bros Discovery Inc
COM SER A
$5.1M187.4K
4.7%
▲+184%
Added · +121K sh
7Adeia Inc
COM
$2.9M121.1K
2.7%
▲New
New position
8Farmer Bros Co
COM
$428K336.7K
0.4%
▲New
New position
Showing all 8 positions

Largest options & derivatives disclosed

Put / call positions from the 13F — totals include every disclosed option leg

Call notional (bullish)$1.1M
TypeUnderlyingNotional valueUnderlying shares
CALL · bullishHALLADOR ENERGY COHNRG$1.1M67K

13F filers disclose option positions at the market value of the underlying the contracts reference, not the premium paid. A put is a bearish bet (it gains if the stock falls); a call is bullish. “Underlying shares” is the share count the contracts control, not a share holding. These legs are excluded from the equity book, weighting, concentration and sector figures above.

Filing history

As-of date vs the date the SEC received each filing

QuarterAs ofFiledPositionsValueForm
Q1 2026Mar 31, 2026May 15, 20269$109.7M13F-HR
Q4 2025Dec 31, 2025Feb 17, 202615$986.3M13F-HR
Q3 2025Sep 30, 2025Nov 14, 20256$52.0M13F-HR
Q2 2025Jun 30, 2025Aug 14, 202528$664.0M13F-HR
Q1 2025Mar 31, 2025May 15, 202513$267.7M13F-HR
Q4 2024Dec 31, 2024Feb 14, 202531$442.6M13F-HR
Q3 2024Sep 30, 2024Nov 14, 202430$463.0M13F-HR
Q2 2024Jun 30, 2024Aug 14, 202424$332.6M13F-HR
Q1 2024Mar 31, 2024May 15, 202418$82.0M13F-HR
Q4 2023Dec 31, 2023Feb 14, 202420$182.1M13F-HR
Q3 2023Sep 30, 2023Nov 14, 202331$896.5M13F-HR
Q2 2023Jun 30, 2023Aug 14, 202320$397.5M13F-HR
Q1 2023Mar 31, 2023May 15, 202317$127.2M13F-HR
Q4 2022Dec 31, 2022Feb 14, 202323$248.5M13F-HR
Q3 2022Sep 30, 2022Nov 14, 202228$942.2M13F-HR
Q2 2022Jun 30, 2022Aug 15, 202253$967.5M13F-HR
Q1 2022Mar 31, 2022May 16, 2022254$1.6B13F-HR
Q4 2021Dec 31, 2021Mar 15, 2022374$1.9B13F-HR/A
Q3 2021Sep 30, 2021Nov 15, 2021220$1.4B13F-HR
Q2 2021Jun 30, 2021Aug 16, 2021190$1.1B13F-HR
Q1 2021Mar 31, 2021May 17, 2021207$782.9M13F-HR
Q4 2020Dec 31, 2020Feb 16, 2021229$633.0M13F-HR
Q3 2020Sep 30, 2020Nov 16, 202095$555.6M13F-HR
Amended / restated
  • Q4 2021 · filed Feb 14, 202213F-HR · superseded

Data source

Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.